Idamida®

Pomalidomide

Therapeutic action

Immunomodulatory agent

Indications

Mantle cell lymphoma / Multiple myeloma / Myelodysplastic syndrome

Presentation

Hard capsules of 1 mg, 2 mg, 3 mg and 4 mg